Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Rev Argent Microbiol ; 55(3): 278-288, 2023.
Article in English | MEDLINE | ID: mdl-37019801

ABSTRACT

Infections, including zoonoses, constitute a threat to human health due to the spread of resistant pathogens. These diseases generate an inflammatory response controlled by a resolving mechanism involving specialized membrane lipid-derived molecules called lipoxins, resolvins, maresins, and protectins. The production of some of these molecules can be triggered by aspirin or statins. Thus, it is proposed that modulation of the host response could be a useful therapeutic strategy, contributing to the management of resistance to antiparasitic agents or preventing drift to chronic, host-damaging courses. Therefore, the present work presents the state of the art on the use of statins or aspirin for the experimental management of parasitic infections such as Chagas disease, leishmaniasis, toxoplasmosis or malaria. The methodology used was a narrative review covering original articles from the last seven years, 38 of which met the inclusion criteria. Based on the publications consulted, modulation of the resolution of inflammation using statins may be feasible as an adjuvant in the therapy of parasitic diseases. However, there was no strong experimental evidence on the use of aspirin; therefore, further studies are needed to evaluate its role inflammation resolution process in infectious diseases.


Subject(s)
Hydroxymethylglutaryl-CoA Reductase Inhibitors , Parasitic Diseases , Animals , Humans , Aspirin/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Docosahexaenoic Acids/therapeutic use , Inflammation/drug therapy , Inflammation/prevention & control , Parasitic Diseases/drug therapy , Parasitic Diseases/prevention & control
2.
Homeopathy ; 110(2): 115-121, 2021 May.
Article in English | MEDLINE | ID: mdl-33368105

ABSTRACT

BACKGROUND: There are relatively few scientific works on the use of homeopathy to manage plant pathogens, particularly nematodes. A handful of studies focused on Meloidogyne spp. parasitizing vegetables have brought contradictory results on nematode control and enhancement of plant tolerance to parasitism. OBJECTIVE: Our goal was to assess the effect of Cina-a well-known anti-nematode ingredient-on Meloidogyne enterolobii parasitizing lettuce. METHODS: Cina was applied daily on nematode-inoculated plants, from the seedling stage until harvest. We tested an evenly spaced range of Hahnemannian concentrations (c), which were applied though irrigation with a constant dose of the ingredient. Several absolute and relative controls were employed to allow the assessment of the effect of Cina on nematode reproduction and lettuce growth. RESULTS: Cina affected growth of non-parasitized plants, both positively and negatively; this effect was modulated by the c applied and the thermal stress suffered by the plants in one of the assays. The effect of Cina on the growth of nematode-parasitized plants was neutral or negative. Cina reduced nematode reproduction by 25-36%. CONCLUSION: Based on the moderate negative effect of Cina on M. enterolobii reproduction, it seems this ingredient may be useful as a complementary strategy for Meloidogyne control. But Cina did not enhance the tolerance of lettuce to Meloidogyne spp.


Subject(s)
Lactuca/drug effects , Materia Medica/standards , Tylenchoidea/drug effects , Animals , Materia Medica/therapeutic use , Parasitic Diseases/drug therapy , Parasitic Diseases/prevention & control
3.
Acta Trop ; 207: 105466, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32302690

ABSTRACT

Omega-3 and omega-6 polyunsaturated fatty acids are synthesized from the essential fatty acids alpha-linolenic acid and linoleic acid, respectively. They are pivotal components of all mammalian cells and were found to be useful in prevention and treatment of a variety of health problems owing to their anti-inflammatory and anti-microbial properties. Omega-3 and omega-6 polyunsaturated fatty acids are further metabolized to anti-inflammatory mediators, such as lipoxins, resolvins, and protectins. Moreover, these polyunsaturated fatty acids were found to have in vivo and in vitro protective efficacies against some parasitic infections. Therefore, dietary intake of polyunsaturated fatty acids should be encouraged because of their considerable beneficial effects.


Subject(s)
Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-6/administration & dosage , Parasitic Diseases/prevention & control , Fatty Acids, Omega-3/pharmacology , Fatty Acids, Omega-6/pharmacology , Fatty Acids, Unsaturated/classification , Humans
4.
Am J Clin Nutr ; 106(2): 657-666, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28615258

ABSTRACT

Background: Children who recover from moderate acute malnutrition (MAM) have high rates of relapse in the year after nutritional recovery. Interventions to decrease these adverse outcomes are needed to maximize the overall effectiveness of supplemental feeding programs (SFPs).Objective: We evaluated the effectiveness of a package of health and nutrition interventions on improving the proportion of children who sustained recovery for 1 y after MAM treatment. We further explored factors related to sustained recovery.Design: We conducted a cluster-randomized clinical effectiveness trial involving rural Malawian children aged 6-62 mo who were enrolled on discharge from an SFP for MAM. We enrolled 718 children at 10 control sites and 769 children at 11 intervention sites. In addition to routine health and nutrition counseling, the intervention group received a package of health and nutrition interventions that consisted of a lipid nutrient supplement, deworming medication, zinc supplementation, a bed net, and malaria chemoprophylaxis. A survival analysis was used to determine the effectiveness of the intervention as well as to identify factors associated with sustained recovery.Results: Of 1383 children who returned for the full 12-mo follow-up period, 407 children (56%) and 347 children (53%) sustained recovery in the intervention and control groups, respectively. There was no significant difference in relapse-free survival curves between the treatment and control groups (P = 0.380; log-rank test). The risk factors for relapse or death after initial recovery were a smaller midupper arm circumference on SFP admission (P = 0.01) and discharge (P < 0.001), a lower weight-for-height z score on discharge (P < 0.01), and the receipt of ready-to-use supplementary food as opposed to ready-to-use therapeutic food during treatment (P < 0.05).Conclusion: The provision of a package of health and nutrition services in addition to traditional SFP treatment has no significant effect on improving sustained recovery in children after treatment of MAM. This trial was registered at clinicaltrials.gov as NCT02351687.


Subject(s)
Child Nutrition Disorders/therapy , Dietary Supplements , Food, Formulated , Food, Fortified , Health Services , Malnutrition/therapy , Nutritional Status , Child , Child Nutrition Disorders/diet therapy , Child Nutritional Physiological Phenomena , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Lipids/therapeutic use , Malaria/prevention & control , Malawi , Male , Malnutrition/diet therapy , Parasitic Diseases/prevention & control , Recurrence , Rural Population , Weight Gain , Zinc/therapeutic use
5.
Trends Parasitol ; 32(9): 739-749, 2016 09.
Article in English | MEDLINE | ID: mdl-27236581

ABSTRACT

Several arthropod taxa live exclusively on vertebrate blood. This food source lacks essential metabolites required for the maintenance of metabolic homeostasis, and as such, these arthropods have formed symbioses with nutrient-supplementing microbes that facilitate their host's 'hematophagous' feeding ecology. Herein we highlight metabolic contributions of bacterial symbionts that reside within tsetse flies, bed bugs, lice, reduviid bugs, and ticks, with specific emphasis on B vitamin and cofactor biosynthesis. Importantly, these arthropods can transmit pathogens of medical and veterinary relevance and/or cause infestations that induce psychological and dermatological distress. Microbial metabolites, and the biochemical pathways that generate them, can serve as specific targets of novel control mechanisms aimed at disrupting the metabolism of hematophagous arthropods, thus combatting pest invasion and vector-borne pathogen transmission.


Subject(s)
Arthropod Vectors/microbiology , Host-Parasite Interactions/physiology , Parasitic Diseases/microbiology , Parasitic Diseases/prevention & control , Animals , Arthropod Vectors/metabolism , Drug Delivery Systems , Homeostasis/physiology , Parasitic Diseases/transmission , Symbiosis
6.
Trends Parasitol ; 32(6): 430-432, 2016 06.
Article in English | MEDLINE | ID: mdl-27105933

ABSTRACT

Anthelminthic resistance is acknowledged worldwide and is a major problem in Aotearoa New Zealand, thus alternative parasite management strategies are imperative. One Health is an initiative linking animal, human, and environmental health. Parasites, plants, and people illustrate the possibilities of providing diverse diets for stock thereby lowering parasite burdens, improving the cultural wellbeing of a local community, and protecting the environment.


Subject(s)
Diet/veterinary , Parasitic Diseases/prevention & control , Preventive Health Services , Animals , Drug Resistance , Environment , Humans , New Zealand , Parasites
7.
Arch Dis Child ; 101(7): 640-7, 2016 07.
Article in English | MEDLINE | ID: mdl-26921274

ABSTRACT

Chagas disease, leishmaniasis, onchocerciasis and lymphatic filariasis are all vectorborne neglected tropical diseases (NTDs) that are responsible for significant disease burden in impoverished children and adults worldwide. As vectorborne parasitic diseases, they can all be targeted for elimination through vector control strategies. Examples of successful vector control programmes for these diseases over the past two decades have included the Southern Cone Initiative against Chagas disease, the Kala-azar Control Scheme against leishmaniasis, the Onchocerciasis Control Programme and the lymphatic filariasis control programme in The Gambia. A common vector control component in all of these programmes is the use of adulticides including dichlorodiphenyltrichloroethane and newer synthetic pyrethroid insecticides against the insect vectors of disease. Household spraying has been used against Chagas disease and leishmaniasis, and insecticide-treated bed nets have helped prevent leishmaniasis and lymphatic filariasis. Recent trends in vector control focus on collaborations between programmes and sectors to achieve integrated vector management that addresses the holistic vector control needs of a community rather than approaching it on a disease-by-disease basis, with the goals of increased efficacy, sustainability and cost-effectiveness. As evidence of vector resistance to currently used insecticide regimens emerges, research to develop new and improved insecticides and novel control strategies will be critical in reducing disease burden. In the quest to eliminate these vectorborne NTDs, efforts need to be made to continue existing control programmes, further implement integrated vector control strategies and stimulate research into new insecticides and control methods.


Subject(s)
Child Health , Insect Vectors , Neglected Diseases/prevention & control , Parasitic Diseases/prevention & control , Animals , Chagas Disease/prevention & control , Chagas Disease/transmission , Filariasis/prevention & control , Filariasis/transmission , Global Health , Humans , Insect Control/methods , Leishmaniasis/prevention & control , Leishmaniasis/transmission , Onchocerciasis/prevention & control , Onchocerciasis/transmission , Parasitic Diseases/transmission
8.
BMJ Open ; 5(12): e009293, 2015 Dec 30.
Article in English | MEDLINE | ID: mdl-26719316

ABSTRACT

INTRODUCTION: There is limited evidence demonstrating the benefits of community-based water, sanitation and hygiene (WASH) programmes on infections with soil-transmitted helminths (STH) and intestinal protozoa. Our study aims to contribute to that evidence base by investigating the effectiveness of combining two complementary approaches for control of STH: periodic mass administration of albendazole, and delivery of a community-based WASH programme. METHODS AND ANALYSIS: WASH for WORMS is a cluster-randomised controlled trial to test the hypothesis that a community-based WASH intervention integrated with periodic mass distribution of albendazole will be more effective in reducing infections with STH and protozoa than mass deworming alone. All 18 participating rural communities in Timor-Leste receive mass chemotherapy every 6 months. Half the communities also receive the community-based WASH programme. Primary outcomes are the cumulative incidence of infection with STH. Secondary outcomes include the prevalence of protozoa; intensity of infection with STH; as well as morbidity indicators (anaemia, stunting and wasting). Each of the trial outcomes will be compared between control and intervention communities. End points will be measured 2 years after the first albendazole distribution; and midpoints are measured at 6 months intervals (12 months for haemoglobin and anthropometric indexes). Mixed-methods research will also be conducted in order to identify barriers and enablers associated with the acceptability and uptake of the WASH programme. ETHICS AND DISSEMINATION: Ethics approval was obtained from the human ethics committees at the University of Queensland, Australian National University, Timorese Ministry of Health, and University of Melbourne. The results of the trial will be published in peer-reviewed journals presented at national and international conferences, and disseminated to relevant stakeholders in health and WASH programmes. This study is funded by a Partnership for Better Health--Project grant from the National Health and Research Council (NHMRC), Australia. TRIAL REGISTRATION NUMBER: ACTRN12614000680662; Pre-results.


Subject(s)
Albendazole/therapeutic use , Hygiene , Intestines/parasitology , Parasites , Parasitic Diseases/prevention & control , Sanitation , Water/parasitology , Adolescent , Adult , Animals , Anthelmintics/therapeutic use , Antiprotozoal Agents/therapeutic use , Child , Child, Preschool , Helminths , Humans , Infant , Parasitic Diseases/parasitology , Research Design , Residence Characteristics , Rural Population , Timor-Leste
9.
Osteoporos Int ; 24(5): 1537-53, 2013 May.
Article in English | MEDLINE | ID: mdl-23160915

ABSTRACT

Interaction with the immune system is one of the most recently established nonclassic effects of vitamin D (VitD). For many years, this was considered to be limited to granulomatous diseases in which synthesis of active 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) or calcitriol is known to be increased. However, recent reports have supported a role for 1,25(OH)2D3 in promoting normal function of the innate and adaptive immune systems. Crucially, these effects seem to be mediated not only by the endocrine function of circulating calcitriol but also via paracrine (i.e., refers to effects to adjacent or nearby cells) and/or intracrine activity (i.e., refers to a hormone acting inside a cell) of 1,25(OH)2D3 from its precursor 25(OH)D3, the main circulating metabolite of VitD. The ability of this vitamin to influence human immune responsiveness seems to be highly dependent on the 25(OH)D3 status of individuals and may lead to aberrant response to infection or even to autoimmunity in those who are lacking VitD. The potential health significance of this has been underlined by increasing awareness of impaired status in populations across the globe. This review will examine the current understanding of how VitD status may modulate the responsiveness of the human immune system. Furthermore, we discuss how it may play a role in host resistance to common pathogens and how effective is its supplementation for treatment or prevention of infectious diseases in humans.


Subject(s)
Communicable Diseases/immunology , Vitamin D/immunology , Adaptive Immunity , Animals , Bacterial Infections/immunology , Bacterial Infections/prevention & control , Dietary Supplements , Disease Susceptibility , Humans , Immunity, Innate , Immunologic Factors/immunology , Immunologic Factors/therapeutic use , Parasitic Diseases/immunology , Parasitic Diseases/prevention & control , Virus Diseases/immunology , Virus Diseases/prevention & control , Vitamin D/blood , Vitamin D/therapeutic use
10.
Turkiye Parazitol Derg ; 36(3): 160-5, 2012.
Article in English | MEDLINE | ID: mdl-23169160

ABSTRACT

OBJECTIVE: Four plant extracts possessing molluscicidal and insecticidal efficacy were evaluated under laboratory conditions versus Biomphalaria alexandrina, Lymnea cailliaudi snails, their egg masses and Culex pipiens larvae. These extracts included Grape seed, Eucalyptus, Pomegranate, Verbesina alcoholic extracts, as well as Eucalyptus oil. METHODS: Different mortalities in the exposed vectors were recorded due to the four plant extracts using different concentrations and exposure time. RESULTS: Total snail mortality LC < sub > 100 < /sub > was (100 ppm/12-24h) for Grape seed, (200 ppm/18-24h) for Eucalyptus, (100 ppm/12-18h) for Pomegranate, (100-200 ppm/24h) for Verbesina alcoholic extracts and (100-200 ppm/12h) for Eucalyptus oil. However, only Eucalyptus, Verbesina alcoholic extracts and Eucalyptus oil revealed snail ovicidal effects. LC < sub > 100 < /sub > was (100-200 ppm/24h), (100-200 ppm/24h) & (100-200 ppm/12-48h) respectively. Moreover, the same plant extracts were able to induce total Culex pipiens larvicidal mortality, LC < sub > 100 < /sub > was (200 ppm/48h). However, Grape seed and Pomegranate alcoholic extracts did not induce either snail ovicidal or Culex pipiens larvicidal total mortalities. Activities of the studied plant extracts were considered using reference molluscicidal (Copper sulfate) and insecticidal (Temephos) substances. CONCLUSION: Egyptian native plants continue to provide a wealth of potential sources for biologically active agents that may have a promising role in the production of safe, biodegradable eco-friendly and natural molluscicidal and insecticidal agents.


Subject(s)
Disease Vectors , Insecticides , Molluscacides , Parasitic Diseases/prevention & control , Plant Extracts , Animals , Biological Assay , Biomphalaria , Culex , Eucalyptus/chemistry , Eucalyptus Oil , Larva , Lymnaea , Lythraceae/chemistry , Monoterpenes , Oils, Volatile , Parasitic Diseases/transmission , Seeds/chemistry , Verbesina/chemistry , Vitis/chemistry
11.
Trends Parasitol ; 26(5): 264-70, 2010 May.
Article in English | MEDLINE | ID: mdl-20400374

ABSTRACT

Tremendous progress has been made in the control and prevention of human parasitic diseases in mainland China in the past 30 years because of China's Reform and Opening to the Outside Policies initiated in 1978. However, parasitic diseases remain a major human health problem, with significant morbidity and mortality as well as adverse socioeconomic consequences. Although soil-transmitted parasitic diseases are in the process of being gradually controlled, food-borne parasitic diseases and emerging parasitic diseases are becoming the focus of new campaigns for control and prevention. This article reviews major trends in human parasitic diseases in mainland China, with perspectives for control.


Subject(s)
Parasitic Diseases/epidemiology , China/epidemiology , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/prevention & control , Demography , Foodborne Diseases/epidemiology , Foodborne Diseases/prevention & control , Humans , National Health Programs/trends , Parasitic Diseases/mortality , Parasitic Diseases/prevention & control , Prevalence
13.
Trans R Soc Trop Med Hyg ; 102(6): 509-19, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18413278

ABSTRACT

This paper suggests that the 'other diseases' of Millennium Development Goal 6 (MDG 6) are ignored by policy-makers and politicians who overfocus on unachievable objectives and targets around the 'big three' diseases of HIV, tuberculosis (TB) and malaria, which if the planet was viewed by aliens would be seen as the only diseases that existed on the planet. The diseases of the majority of the poor represent 'low hanging fruit' for control and elimination and opportunities are ignored despite the availability of cheap or donated drugs and ample evidence that such interventions are effective and reduce incidence, as well as mortality and morbidity. The time frame available to achieve the MDGs of some 7-8 years requires a re-evaluation of what can be done with the tools available now and which can address the problems faced by the majority of poor people afflicted by disabling conditions which together represent a global burden greater than malaria or TB. The author considers also the volume of research relevant to the MDGs and their achievement is distorted by the focus on high tech end research which cannot be delivered by 2015 and that in terms of the 90:10 gap in research relevant to the problems of the poorest the real gap is 99:1. The concepts of distortion of donor funding for diseases of MDG 6 for implementation of largely curative interventions which do not reduce incidence as well as research which addresses problems that cannot reach poor people in the time frame to 2015 is emphasised. New paradigms are required if any impact on MDG 6 is to be achieved recognising the needs of the majority via an equitable distribution of funding.


Subject(s)
Health Policy , Health Priorities/standards , Health Services Accessibility/standards , Healthy People Programs/standards , Parasitic Diseases/prevention & control , Tropical Medicine/standards , Developing Countries , Global Health , Goals , Health Priorities/organization & administration , Health Services Accessibility/organization & administration , Humans , International Cooperation , Socioeconomic Factors , Time Factors , United Nations
15.
Trends Parasitol ; 23(5): 223-9, 2007 May.
Article in English | MEDLINE | ID: mdl-17383234

ABSTRACT

Japanese researchers continue to discover new means to combat parasites and make important contributions toward developing tools for global control of parasitic diseases. Streptomyces avermectinius, the source of ivermectin, was discovered in Japan in the early 1970s and renewed and vigorous screening of microbial metabolites in recent years has led to the discovery of new antiprotozoals and anthelminthics, including antimalarial drugs. Intensive studies of parasite energy metabolism, such as NADH-fumarate reductase systems and the synthetic pathways of nucleic acids and amino acids, also contribute to the identification of novel and unique drug targets.


Subject(s)
Antiparasitic Agents/therapeutic use , Bacteria/metabolism , Biological Products/biosynthesis , Biological Products/therapeutic use , Parasitic Diseases/prevention & control , Animals , Antimalarials/therapeutic use , Antiprotozoal Agents/therapeutic use , Biomedical Research , Drug Design , Drug Evaluation, Preclinical , Humans , Japan , Pharmaceutical Preparations , Technology, Pharmaceutical
16.
Adv Parasitol ; 61: 1-45, 2006.
Article in English | MEDLINE | ID: mdl-16735161

ABSTRACT

The control of parasitic diseases of humans has been undertaken since the aetiology and natural history of the infections was recognized and the deleterious effects on human health and well-being appreciated by policy makers, medical practitioners and public health specialists. However, while some parasitic infections such as malaria have proved difficult to control, as defined by a sustained reduction in incidence, others, particularly helminth infections can be effectively controlled. The different approaches to control from diagnosis, to treatment and cure of the clinically sick patient, to control the transmission within the community by preventative chemotherapy and vector control are outlined. The concepts of eradication, elimination and control are defined and examples of success summarized. Overviews of the health policy and financing environment in which programmes to control or eliminate parasitic diseases are positioned and the development of public-private partnerships as vehicles for product development or access to drugs for parasite disease control are discussed. Failure to sustain control of parasites may be due to development of drug resistance or the failure to implement proven strategies as a result of decreased resources within the health system, decentralization of health management through health-sector reform and the lack of financial and human resources in settings where per capita government expenditure on health may be less than $US 5 per year. However, success has been achieved in several large-scale programmes through sustained national government investment and/or committed donor support. It is also widely accepted that the level of investment in drug development for the parasitic diseases of poor populations is an unattractive option for pharmaceutical companies. The development of partnerships to specifically address this need provides some hope that the intractable problems of the treatment regimens for the trypanosomiases and leishmaniases can be solved in the not too distant future. However, it will be difficult to implement and sustain such interventions in fragile health services often in settings where resources are limited but also in unstable, conflict-affected or post-conflict countries. Emphasis is placed on the importance of co-endemicity and polyparasitism and the opportunity to control parasites susceptible to cost-effective and proven chemotherapeutic interventions for a package of diseases which can be implemented at low cost and which would benefit the poorest and most marginalized groups. The ecology of parasitic diseases is discussed in the context of changing ecology, environment, sociopolitical developments and climate change. These drivers of global change will affect the epidemiology of parasites over the coming decades, while in many of the most endemic and impoverished countries parasitic infections will be accorded lower priority as resourced stressed health systems cope with the burden of the higher-profile killing diseases viz., HIV/AIDS, TB and malaria. There is a need for more holistic thinking about the interactions between parasites and other infections. It is clear that as the prevalence and awareness of HIV has increased, there is a growing recognition of a host of complex interactions that determine disease outcome in individual patients. The competition for resources in the health as well as other social sectors will be a continuing challenge; effective parasite control will be dependent on how such resources are accessed and deployed to effectively address well-defined problems some of which are readily amenable to successful interventions with proven methods. In the health sector, the problems of the HIV/AIDS and TB pandemics and the problem of the emerging burden of chronic non-communicable diseases will be significant competitors for these limited resources as parasitic infections aside from malaria tend to be chronic disabling problems of the poorest who have limited access to scarce health services and are representative of the poorest quintile. Prioritization and advocacy for parasite control in the national and international political environments is the challenge.


Subject(s)
Community Health Planning/organization & administration , Parasitic Diseases/prevention & control , Preventive Health Services/organization & administration , Public Health/standards , Animals , Climate , Community Health Planning/standards , Community Health Planning/trends , Disease Reservoirs , Disease Vectors , Global Health , Health Policy/economics , Health Policy/trends , Humans , Parasitic Diseases/epidemiology , Preventive Health Services/standards , Public Health/economics , Public Health/methods , Terminology as Topic
17.
Trends Parasitol ; 21(10): 462-8, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16099722

ABSTRACT

Plant essential oils (and/or active components) can be used as alternatives or adjuncts to current antiparasitic therapies. Garlic oil has broad-spectrum activity against Trypanosoma, Plasmodium, Giardia and Leishmania, and Cochlospermum planchonii and Croton cajucara oils specifically inhibit Plasmodium falciparum and Leishmania amazonensis, respectively. Some plant oils have immunomodulatory effects that could modify host-parasite immunobiology, and the lipid solubility of plant oils might offer alternative, transcutaneous delivery routes. The emergence of parasites resistant to current chemotherapies highlights the importance of plant essential oils as novel antiparasitic agents.


Subject(s)
Parasitic Diseases/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Animals , Host-Parasite Interactions/drug effects , Humans , Parasitic Diseases/prevention & control , Plant Oils/therapeutic use
19.
Arch Inst Pasteur Tunis ; 80(1-4): 29-33, 2003.
Article in French | MEDLINE | ID: mdl-15941065

ABSTRACT

In order to fight digestive and urinary parasitoses, a national program of surveillance has been founded. The screening of these parasitoses among the non permanent resident students in Tunisia (ENRPTS) is one of the main actions of this program. Among 2560 ENRPTS tested in the laboratory of Parasitologie of Institut Pasteur of Tunis, between 1998 and 2002, 674 were infected by parasites, which represents a global prévalence of 26.3%. The intestinal protozoa constitute the majority of parasites identified (87.4%). Entamoeba histolytica has been isolated in 89 cases, essentially from students from tropical African countries. Urinary bilharziosis has been diagnosed in 25 cases. These results confirm the utility of the control of the ENRPTS. The precocious tracking permits to avoid the introduction and the dissemination of parasites already absent or rare in our country.


Subject(s)
Emigration and Immigration , Intestinal Diseases, Parasitic/diagnosis , Mass Screening/methods , Parasitic Diseases/diagnosis , Students/statistics & numerical data , Urinary Tract Infections/diagnosis , Africa/ethnology , Asia/ethnology , Emigration and Immigration/statistics & numerical data , Europe/ethnology , Humans , Incidence , Intestinal Diseases, Parasitic/ethnology , Intestinal Diseases, Parasitic/parasitology , Intestinal Diseases, Parasitic/prevention & control , Mass Screening/standards , National Health Programs , Parasitic Diseases/ethnology , Parasitic Diseases/parasitology , Parasitic Diseases/prevention & control , Population Surveillance , Prevalence , Residence Characteristics/statistics & numerical data , Retrospective Studies , Risk Factors , School Health Services/organization & administration , Surveys and Questionnaires , Tunisia/epidemiology , Universities , Urinary Tract Infections/ethnology , Urinary Tract Infections/parasitology , Urinary Tract Infections/prevention & control
20.
Acta sci ; 23(3): 725-729, jun. 2001. tab
Article in Portuguese | LILACS | ID: lil-343971

ABSTRACT

Desenvolvendo um trabalho de parceria entre universidade e comunidade, o projeto teve por objetivo geral proporcionar a participação de acadêmicos em levantamento das principais dúvidas e apresentar propostas de solução sobre problemas de saúde de famílias residentes próximas à Associação Kairós, Maringá/PR. Dez famílias foram selecionadas para o trabalho. Foram eleitos como assuntos para esclarecimento: parasitoses, doenças transmissíveis, dengue, primeiros-socorros, prevenção de câncer, diabetes, hipertensão, plantas medicinais, nutrição, aleitamento materno e alimentação alternativa. Os assuntos foram apresentados às famílias através de minicursos para os adultos e para as crianças, sob a forma de ruas de recreio e gincanas. Realizou-se exame parasitológico de fezes de todos os membros das famílias que receberam tratamento específico e esclarecimentos sobre os parasitas. A avaliação do trabalho foi realizada através de exames parasitológicos após o tratamento e atividades pré-elaboradas a respeito dos conhecimentos adquiridos. Constatou-se uma queda na prevalência dos parasitas e houve melhoria de hábitos de higiene.Palavras-chave: educação sanitária, enteroparasitoses, profilaxia


Subject(s)
Humans , Male , Female , Child , Adolescent , Adult , Dengue , Parasitic Diseases/epidemiology , Parasitic Diseases/prevention & control , Hygiene
SELECTION OF CITATIONS
SEARCH DETAIL